News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
3,014 Results
Type
Article (28)
Press Release (2986)
Section
Business (1335)
Career Advice (2)
Deals (180)
Drug Development (631)
FDA (95)
Job Trends (268)
News (2105)
Policy (116)
Tag
Academia (3)
Alliances (42)
Alzheimer's disease (27)
Approvals (104)
Artificial intelligence (1)
Bankruptcy (1)
Best Places to Work (297)
Breast cancer (4)
Cancer (49)
Career advice (1)
Clinical research (621)
Collaboration (4)
Compensation (1)
COVID-19 (4)
Data (63)
Diabetes (1)
Diagnostics (20)
Drug discovery (1)
Drug pricing (1)
Earnings (1403)
Events (324)
FDA (119)
Frontotemporal dementia (1)
Funding (2)
Generative AI (1)
Gene therapy (4)
GLP-1 (7)
Government (9)
Guidances (2)
Healthcare (85)
Infectious disease (4)
Inflammatory bowel disease (2)
IPO (160)
IRA (1)
Job creations (1)
Job search strategy (1)
Kidney cancer (2)
Layoffs (2)
Legal (1)
Lung cancer (22)
Lymphoma (6)
Manufacturing (1)
MASH (3)
Medical device (56)
Medtech (56)
Mergers & acquisitions (23)
Metabolic disorders (5)
Multiple sclerosis (2)
NASH (1)
Neuroscience (33)
NextGen: Class of 2025 (9)
Non-profit (4)
Northern California (31)
Obesity (1)
Opinion (1)
Parkinson's disease (1)
People (8)
Phase I (94)
Phase II (188)
Phase III (367)
Pipeline (35)
Policy (1)
Postmarket research (27)
Preclinical (12)
Prostate cancer (2)
Radiopharmaceuticals (6)
Rare diseases (5)
Regulatory (138)
Reports (2)
Research institute (6)
Resumes & cover letters (1)
Rett syndrome (1)
Schizophrenia (2)
Southern California (13)
Startups (3)
United States (242)
Vaccines (3)
Date
Today (5)
Last 7 days (10)
Last 30 days (52)
Last 365 days (429)
2025 (97)
2024 (419)
2023 (423)
2022 (418)
2021 (481)
2020 (310)
2019 (202)
2018 (150)
2017 (116)
2016 (39)
2015 (73)
2014 (43)
2013 (25)
2012 (28)
2011 (23)
2010 (22)
Location
Asia (330)
Australia (13)
California (48)
Canada (15)
China (8)
Connecticut (1)
Delaware (12)
Europe (591)
Florida (7)
Georgia (2)
Illinois (5)
Indiana (16)
Japan (8)
Maryland (11)
Massachusetts (33)
Minnesota (1)
New Jersey (43)
New York (26)
North Carolina (8)
Northern California (31)
Ohio (2)
Pennsylvania (18)
South America (5)
Southern California (13)
Texas (7)
Utah (5)
Washington State (2)
3,014 Results for "%E2%80%9D%20target=".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
XORTX Announces Update for Discussion with the FDA
March 19, 2025
·
8 min read
Press Releases
Lexicon Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates
March 6, 2025
·
15 min read
Press Releases
New study results reinforce TAGRISSO® (osimertinib) as the backbone therapy for EGFR-mutated lung cancer across stages and settings
March 26, 2025
·
19 min read
Press Releases
MacroGenics Provides Update on Corporate Progress and 2024 Financial Results
March 20, 2025
·
13 min read
Press Releases
Integra LifeSciences Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides 2025 Financial Guidance
February 25, 2025
·
26 min read
Press Releases
Arcus Biosciences Reports Fourth-Quarter and Full-Year 2024 Financial Results and Provides a Pipeline Update
February 25, 2025
·
15 min read
Press Releases
Piramal Pharma Limited Announces Results for Q3 and 9M FY25
January 29, 2025
·
6 min read
Press Releases
4DMT Reports Full Year 2024 Financial Results, Operational Highlights and Expected Upcoming Milestones
March 3, 2025
·
11 min read
Press Releases
New Data Demonstrated Best-in-Class Potential for Casdatifan, a HIF-2a Inhibitor, in Patients with Metastatic Kidney Cancer
February 17, 2025
·
9 min read
Press Releases
Antengene to Present Results From Four Cutting Edge Preclinical Studies at AACR 2025 with Focuses Including AnTenGagerTM TCEs and Synthetic Lethality
March 26, 2025
·
10 min read
1 of 302
Next
